BaradellL.B., BrysonH.M.Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs1994; 47: 471–505.
2.
BarbhaiyaR.H., KnuppC.A., PfefferM., ZaccardelliD., DukesG.M., MatternW.Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.Antimicrob Agents Chemother1992; 36: 1387–91.
3.
LiP.K.T., IpM., LawM.C., SzetoC.C., LeungC.B., WongT.Y.H.Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis.Perit Dial Int2000; 20: 232–41.
4.
LuchtR.F., FresardA., BerthelotP., FarizonF., AubertG., DorcheG.Prolonged treatment of chronic Pseudomonas aeruginosa osteomyelitis with a combination of two effective antibiotics.Infection1994; 22: 276–80.
5.
BarbhaiyaR.H., KnuppC.A., ForgueS.T., ShyuW.C., PappE.A., PittmanK.A.High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine.Antimicrob Agents Chemother1987; 31: 55–9.
6.
CraigW.A.Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men.Clin Infect Dis1998; 26: 1–12.
7.
TamV.H., McKinnonP.S., AkinsR.L., RybakM.J., DrusanoG.L.Pharmacodynamics of cefepime in patients with gram-negative infections.J Antimicrob Chemother2002; 50: 425–8.
LowC.L., GopalakrishnaK., LyeW.C.Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.J Am Soc Nephrol2000; 11: 1117–21.
10.
MorseG.D., FarolinoD.F., ApicellaM.A., WalscheJ.J.Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.Antimicrob Agents Chemother1987; 31: 173–7.
11.
WilliamsonJ.C., VollesD.F., LynchP.L., RogersP.D., HaverstickD.M.Stability of cefepime in peritoneal dialysis solution.Ann Pharmacother1999; 33: 906–9.
